Article Details
Retrieved on: 2022-08-12 12:27:36
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
... or those who were recently treated with a B-cell–depleting monoclonal antibody had the lowest rates of developed antibodies, the study said.
Article found on: www.managedhealthcareexecutive.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here